Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
16.25
-0.23 (-1.40%)
At close: May 22, 2026, 4:00 PM EDT
16.24
-0.01 (-0.06%)
After-hours: May 22, 2026, 7:58 PM EDT

Takeda Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
50,74358,51746,80043,60151,23745,316
Market Cap Growth
12.98%25.04%7.34%-14.90%13.07%-20.63%
Enterprise Value
81,32282,06270,55870,04977,51972,147
Last Close Price
16.2518.5214.8713.8916.4814.32
PE Ratio
42.0749.1066.3246.1521.6723.91
PS Ratio
1.792.061.531.551.691.55
PB Ratio
1.041.191.010.911.070.97
P/TBV Ratio
0.010.010.010.010.010.01
P/FCF Ratio
9.3310.728.1912.208.135.52
P/OCF Ratio
7.758.916.649.226.964.91
EV/Sales Ratio
2.872.892.312.492.562.46
EV/EBITDA Ratio
9.6011.529.5811.268.918.41
EV/EBIT Ratio
20.6831.8430.8849.5420.9819.06
EV/FCF Ratio
14.9615.0412.3519.6112.308.79
Debt / Equity Ratio
0.560.560.570.620.640.73
Debt / EBITDA Ratio
4.324.324.095.143.804.16
Debt / FCF Ratio
5.645.645.278.965.244.35
Net Debt / Equity Ratio
0.550.550.590.600.600.61
Net Debt / EBITDA Ratio
3.763.763.724.643.323.32
Net Debt / FCF Ratio
4.914.914.808.084.583.47
Asset Turnover
0.290.300.310.290.300.30
Inventory Turnover
1.121.201.301.301.352.35
Quick Ratio
0.620.620.450.510.500.75
Current Ratio
1.271.271.011.110.971.21
Return on Equity (ROE)
2.49%2.61%1.52%2.12%5.27%4.55%
Return on Assets (ROA)
1.96%2.03%1.44%4.02%3.06%2.92%
Return on Invested Capital (ROIC)
2.12%2.18%1.54%4.36%3.38%3.21%
Return on Capital Employed (ROCE)
3.17%3.30%2.79%1.76%4.36%4.60%
Earnings Yield
2.38%2.04%1.51%2.17%4.61%4.18%
FCF Yield
10.71%9.33%12.21%8.19%12.30%18.12%
Dividend Yield
1.55%3.37%4.30%4.36%4.11%5.20%
Payout Ratio
33.45%162.65%280.28%199.34%88.14%123.30%
Buyback Yield / Dilution
0.16%0.16%-1.58%-0.67%0.46%-0.23%
Total Shareholder Return
1.71%3.53%2.72%3.70%4.58%4.97%
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q